Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 89591

1 recalled-product record grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 11, 2022
Product types
Drug
Classifications
Class I
Statuses
Terminated
Recalling firm wording
Revive Rx LLC dba Revive Rx Pharmacy

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

HCG 6,000iu (lyo) Human Chorionic Gonadotropin Inj., For Sub-Q or IM Use Only, Not For IV Use, Vial, Rx Only, Compounded By: Revive Rx 3831 Golf Dr., Houston, TX 77018, NDC: 88888-1739-01.

D-0648-2022
Recall number
D-0648-2022
Initiated
February 11, 2022
Classification
Class I
Status
Terminated
Quantity
115 vials

App-derived interpretation

Microbial contamination reason.microbial_contamination · v1.0.0
bacterial contamination

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Non-sterility; bacterial contamination identified as Paenibacillus lautus.

Code information

Lot: 631359 BUD: 05/01/2022

Distribution pattern

Nationwide in the US.